Mumbai
Tier 1
$30,000 - $75,000
Higher range reflects complex donor type, isolation care, infection treatment, and tertiary hematology support.
Hematology transplant cost
Plan BMT cost across India with city-wise USD ranges, donor matching, conditioning therapy, isolation room stay, infection control, blood product support, and follow-up planning.
How much does bone marrow transplant cost in India?
Bone marrow transplant in India commonly ranges from $22,000 to $75,000 or more depending on whether the transplant is autologous, matched sibling, matched unrelated, haploidentical, or cord-blood based. Donor matching, conditioning chemotherapy, isolation stay, infection control, transfusions, ICU backup, medicines, and complications are the biggest cost drivers.
City-wise cost
These ranges are planning bands. A hospital-backed quote should be requested after reports, diagnosis, and fitness details are reviewed.
Tier 1
$30,000 - $75,000
Higher range reflects complex donor type, isolation care, infection treatment, and tertiary hematology support.
Tier 1
$29,000 - $72,000
Useful for hematology transplant programs and unrelated or haploidentical donor review.
Tier 1
$30,000 - $75,000
Often selected for premium transplant units and international patient coordination.
Tier 1
$28,000 - $70,000
Strong for hematology depth, donor workup, and complex infection support.
Tier 1
$27,000 - $68,000
Established option for marrow transplant programs and long-stay care.
Tier 1
$26,000 - $66,000
Can offer tertiary hematology care with comparatively efficient packages.
Major metro
$25,000 - $60,000
Consider only in hospitals with verified transplant-unit depth.
Major metro
$24,000 - $58,000
Can be competitive for selected hematology transplant pathways.
Major metro
$24,000 - $57,000
Useful for eastern-region patients when transplant-unit capability is confirmed.
Tier 2
$22,000 - $50,000
Use selectively and only after confirming isolation rooms, blood bank, ICU, and hematology coverage.
Tier 2
$22,000 - $49,000
Usually better for pre/post coordination unless a full BMT unit is verified.
Tier 2
$23,000 - $52,000
Confirm transplant volume, infection protocols, and emergency support before choosing.
Tier choice
Unrelated donor, haploidentical, active infection, relapse, or high-risk disease usually needs Tier 1 transplant depth.
Lower city cost is relevant only when isolation rooms, blood bank, ICU, and hematology transplant team are proven.
Accommodation, food safety, attendant support, and repeated blood tests can become major non-medical costs.
Included
Transplant-unit admission, nursing, isolation room use, and routine monitoring for the planned package period.
Ask how many isolation days are included.
Chemotherapy or conditioning medicines before stem cell infusion as per protocol.
Drug intensity varies by disease and donor type.
Collection, processing, preservation, and infusion steps when included in the hospital plan.
Donor-source details must be written.
Standard labs, transfusion coordination, and supportive medicines during the expected transplant window.
High-cost infection medicines may be separate.
Not included
HLA typing, donor testing, unrelated donor registry, donor travel, or repeat matching tests.
Donor pathway can change total cost.
Antifungals, antivirals, ICU, ventilator support, or prolonged antibiotics.
Common high-cost risk in BMT.
Graft-versus-host disease medicines, scopes, biopsies, admissions, and long-term immune suppression.
Relevant in allogeneic transplant.
Accommodation near hospital, attendant stay, food, transport, and frequent post-discharge blood tests.
Plan this from day one.
Cost drivers
Autologous transplant is usually lower than matched sibling, unrelated donor, haploidentical, or cord-blood transplant.
Donor type drives cost.
Active disease, relapse, infection, poor counts, or organ weakness can increase admission and medicine needs.
Pre-transplant fitness matters.
Delayed engraftment or infection can extend isolation and monitoring.
Longer stay increases cost.
Platelets, packed cells, plasma, irradiated products, and special testing can add cost.
Ask what is bundled.
Immunosuppression, antivirals, antifungals, and prophylaxis can continue after discharge.
Not just admission cost.
Reports
The report checklist is different for each treatment so every cost page avoids generic duplicated content.
BMT estimates need diagnosis, donor status, disease response, infection history, and organ fitness.
Bone marrow biopsy, flow cytometry, cytogenetics, molecular markers, and latest disease status are essential.
Chemotherapy cycles, relapse dates, infections, transfusions, and response scans influence risk.
Sibling HLA reports, donor relationship, donor health, or unrelated donor search status decide the pathway.
Heart, lung, liver, kidney, viral markers, dental review, and active infection status affect timing.
Hospital selection
Confirm HEPA or protective isolation setup, trained transplant nurses, infection-control protocol, and transplant volume.
Core safety factor.
Platelets, irradiated products, cultures, viral monitoring, and rapid lab turnaround should be available.
Daily support matters.
Ask about ICU, infectious disease team, antifungal access, dialysis, and ventilator support.
Complications can escalate quickly.
Clarify visits, medicines, fever hotline, GVHD monitoring, and home-country handoff.
BMT continues after discharge.
Patient journey
Hematology confirms disease status, transplant indication, donor options, and fitness for intensive treatment.
HLA matching, donor testing, relationship documents, and hospital approvals are completed before admission.
Conditioning therapy, stem cell infusion, isolation care, blood support, and infection monitoring occur in hospital.
Frequent blood tests, medicines, fever response, and local stay near hospital are planned before return travel.
Recovery planning
Food safety, mask use, fever response, visitor limits, and hygiene rules should be explained clearly.
Discharge depends on blood count recovery, infection status, oral intake, and medicine tolerance.
Vaccination schedule, immune suppression, GVHD warning signs, and relapse surveillance should be documented.
Questions
Cost depends on donor type, disease status, conditioning protocol, isolation stay, blood products, infection medicines, ICU need, and post-transplant complications.
Usually yes. Allogeneic transplant needs donor workup, immune suppression, GVHD monitoring, and higher infection-control complexity.
Only in selected hospitals with a verified BMT unit, isolation rooms, hematology transplant team, blood bank, ICU, and infection-control depth.
Diagnosis reports, marrow biopsy, flow cytometry, cytogenetics, prior treatment records, HLA reports, donor details, infection tests, and organ fitness reports are needed.
Not always. HLA typing, donor testing, registry search, donor travel, and repeat tests should be confirmed separately.
Many patients need several weeks to months including evaluation, transplant admission, engraftment, and close follow-up before safe travel.
Severe infection, ICU, antifungal medicines, blood products, delayed engraftment, GVHD care, and extended local stay can add significant cost.
Yes. Virello can compare transplant-unit depth, donor pathway, city fit, package inclusions, infection support, and post-discharge planning.